Sitaraghav Rao Gollapudi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Sitaraghav Rao Gollapudi has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
Lester A. Mitscher
11 shared publicationsNoboru Motohashi
Meiji Pharmaceutical University, Japan
7 shared publicationsJyothirmayi Vadapalli
Acharya Nagarjuna University, India
4 shared publicationsKelly Kindscher
Department of Medicinal Chemistry, The University of Kansas, Lawrence, KS
4 shared publicationsSteven Drake
Department of Medicinal Chemistry, Kansas University, Lawrence, KS 66045 U.S.A.
4 shared publicationsAbbas K. Samadi
Department of Surgery, University of Kansas Medical Center, Kansas City, KS, USA
3 shared publications
Latest Publications
- Open Access
- 23 January 2020
- Published by Lupine Publishers LLC in Open Access Journal of Oncology and Medicine
- Vol. 3 (3) , 276-283
Implication of Integrated in Silico Docking and Moma Simulation for the Development of Curcuminoids as Sphingosine Kinase 1 (SK1) Inhibitors for Cancer Treatment
Sphingosine kinase 1 (SphK1) is generally locolaized in cytosol and belong to a class of guanosine triphosphate (GTP. G)-binding protein (G-protein)-coupled receptor kinases (GRK).
- 23 January 2020
- Published by Lupine Publishers LLC in Open Access Journal of Oncology and Medicine
- Vol. 3 (3) , 276-283
Open AccessImplication of Integrated in Silico Docking and Moma Simulation for the Development of Curcuminoids as Sphingosine Kinase 1 (SK1) Inhibitors for Cancer Treatment
Sphingosine kinase 1 (SphK1) is generally locolaized in cytosol and belong to a class of guanosine triphosphate (GTP. G)-binding protein (G-protein)-coupled receptor kinases (GRK).
- Open Access
- 13 November 2018
- Published by Biomedical Research Network, LLC in Biomedical Journal of Scientific & Technical Research
- Vol. 11 (1) , 001-010
Integrated in Silico Docking and MOMA Simulation Methods Reveal Rottlerin as a Potent Janus kinase 2 (JAK2) Inhibitor
Janus kinase 2 (JAK2) is a prospective drug target for myeloproliferative neoplasms, mainly polycythemia Vera, essential thrombocythemia and primary myelofibrosis disorders. JAK2 abnormalities are mainly identified in myeloid neoplasms.
- 13 November 2018
- Published by Biomedical Research Network, LLC in Biomedical Journal of Scientific & Technical Research
- Vol. 11 (1) , 001-010
Open AccessIntegrated in Silico Docking and MOMA Simulation Methods Reveal Rottlerin as a Potent Janus kinase 2 (JAK2) Inhibitor
Janus kinase 2 (JAK2) is a prospective drug target for myeloproliferative neoplasms, mainly polycythemia Vera, essential thrombocythemia and primary myelofibrosis disorders. JAK2 abnormalities are mainly identified in myeloid neoplasms.
- Open Access
- 31 May 2018
- Published by Biomedical Research Network, LLC in Biomedical Journal of Scientific & Technical Research
- Vol. 5 (1) , 001-005
In Silico Docking Studies of Alkannin and Shikonin with Heat Shock Protein-90 (Hsp90)
- 31 May 2018
- Published by Biomedical Research Network, LLC in Biomedical Journal of Scientific & Technical Research
- Vol. 5 (1) , 001-005
Open AccessIn Silico Docking Studies of Alkannin and Shikonin with Heat Shock Protein-90 (Hsp90)
- Open Access
- 1 January 2018
- Published by Scitechnol Biosoft Pvt. Ltd. in Medical & Clinical Reviews
- Vol. 04 (02)
The Prominence of Gerontology and Geriatrics in Improving Lifestyle of the Elderly
- 1 January 2018
- Published by Scitechnol Biosoft Pvt. Ltd. in Medical & Clinical Reviews
- Vol. 04 (02)
Open AccessThe Prominence of Gerontology and Geriatrics in Improving Lifestyle of the Elderly
- Open Access
- 1 January 2018
- Published by Scitechnol Biosoft Pvt. Ltd. in Medical & Clinical Reviews
- Vol. 4 (2)
Co-enzyme Q10 (Ubiquinone): It's Implication in Improving the Life Style of the Elderly
Coenzyme Q10 (CoQ10) (1) is lipid-soluble and an important mitochondrial redox component, endogenously produced antioxidant in the human organisms. CoQ10 (1) plays an important role in the production of cellular energy, strengthens the immune system and acts as a free radical scavenger. Aging, poor eating habits, infections and stress affect the amounts of CoQ10 (1) in the humans. As human beings age, they begin to lose the ability to synthesize CoQ10 (1) from food resulting in its deficiency. CoQ10 (1) facilitates the production of adenosine triphosphate (ATP) in the mitochondria by participating in redox reactions within the electron transport chain. Cardiovascular disease deaths in elders are 80% in males and 75% in females. The average age of death from cardiovascular diseases in the developing world is 68 years and in developed world it is 80 years. Cardiovascular disease onset is 7-10 years earlier in men as compared to women. A low level of myocardial CoQ10 (1) is related to the severity of heart failure. Long-term CoQ10 (1) treatment of patients with chronic heart failure is safe and reduces major adverse cardiovascular complications.
- 1 January 2018
- Published by Scitechnol Biosoft Pvt. Ltd. in Medical & Clinical Reviews
- Vol. 4 (2)
Open AccessCo-enzyme Q10 (Ubiquinone): It's Implication in Improving the Life Style of the Elderly
Coenzyme Q10 (CoQ10) (1) is lipid-soluble and an important mitochondrial redox component, endogenously produced antioxidant in the human organisms. CoQ10 (1) plays an important role in the production of cellular energy, strengthens the immune system and acts as a free radical scavenger. Aging, poor eating habits, infections and stress affect the amounts of CoQ10 (1) in the humans. As human beings age, they begin to lose the ability to synthesize CoQ10 (1) from food resulting in its deficiency. CoQ10 (1) facilitates the production of adenosine triphosphate (ATP) in the mitochondria by participating in redox reactions within the electron transport chain. Cardiovascular disease deaths in elders are 80% in males and 75% in females. The average age of death from cardiovascular diseases in the developing world is 68 years and in developed world it is 80 years. Cardiovascular disease onset is 7-10 years earlier in men as compared to women. A low level of myocardial CoQ10 (1) is related to the severity of heart failure. Long-term CoQ10 (1) treatment of patients with chronic heart failure is safe and reduces major adverse cardiovascular complications.
- 8 February 2012
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 75 (2) , 306
Correction to Cytotoxic Withanolide Constituents of Physalis longifolia
- 8 February 2012
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 75 (2) , 306
Correction to Cytotoxic Withanolide Constituents of Physalis longifolia
- Open Access
- 1 January 2012
- Published by Pharmaceutical Society of Japan in Chemical and Pharmaceutical Bulletin
- Vol. 60 (10) , 1234-1239
Minor Withanolides of Physalis longifolia: Structure and Cytotoxicity
In our recent publication on bioactive guided isolation of compounds from Physalis longifolia (Solanaceae) novel anti-proliferative agents withalongolides A (4) and B (5), and their highly cytotoxic analogues, withalongolide A 4,19,27-triacetate (4a) and withalongolide B 4,19-diacetate (5a) were elucidated. In this study, the two lead compounds (4, 5) were re-isolated in gram quantities for the purpose of further analogue preparation and in vivo testing that would continue to probe structure–activity relationships. During this process, two additional withanolides, named withalongolides O (1) and P (2), were elucidated. Their structures were determined by spectroscopic techniques with 1 being subsequently confirmed by X-ray crystallographic analysis. Utilizing a MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] viability assay, withalongolide O (1) and its 4,7-diaceatate (1a), both containing the functionalities of Δ2-1-oxo- in A ring, a 5β,6β-epoxy in B ring, and a lactone ring in the nine-carbon side chain, exhibited potent cytotoxicity against human head and neck squamous cell carcinoma (JMAR and MDA-1986), melanoma (B16F10 and SKMEL-28), and normal fetal lung fibroblast (MRC-5) cells with IC50 values in the range between 0.15 and 2.95 µM. In addition, the previously reported α orientation of 7-acetate group in acnistins C and D should be revised to the β orientation on the basis of NMR data comparison.
- 1 January 2012
- Published by Pharmaceutical Society of Japan in Chemical and Pharmaceutical Bulletin
- Vol. 60 (10) , 1234-1239
Open AccessMinor Withanolides of Physalis longifolia: Structure and Cytotoxicity
In our recent publication on bioactive guided isolation of compounds from Physalis longifolia (Solanaceae) novel anti-proliferative agents withalongolides A (4) and B (5), and their highly cytotoxic analogues, withalongolide A 4,19,27-triacetate (4a) and withalongolide B 4,19-diacetate (5a) were elucidated. In this study, the two lead compounds (4, 5) were re-isolated in gram quantities for the purpose of further analogue preparation and in vivo testing that would continue to probe structure–activity relationships. During this process, two additional withanolides, named withalongolides O (1) and P (2), were elucidated. Their structures were determined by spectroscopic techniques with 1 being subsequently confirmed by X-ray crystallographic analysis. Utilizing a MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] viability assay, withalongolide O (1) and its 4,7-diaceatate (1a), both containing the functionalities of Δ2-1-oxo- in A ring, a 5β,6β-epoxy in B ring, and a lactone ring in the nine-carbon side chain, exhibited potent cytotoxicity against human head and neck squamous cell carcinoma (JMAR and MDA-1986), melanoma (B16F10 and SKMEL-28), and normal fetal lung fibroblast (MRC-5) cells with IC50 values in the range between 0.15 and 2.95 µM. In addition, the previously reported α orientation of 7-acetate group in acnistins C and D should be revised to the β orientation on the basis of NMR data comparison.
- 18 November 2011
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 74 (12) , 2532-2544
Cytotoxic Withanolide Constituents of Physalis longifolia
Fourteen new withanolides, 1–14, named withalongolides A–N, respectively, were isolated from the aerial parts of Physalis longifolia together with eight known compounds (15–22). The structures of compounds 1–14 were elucidated through spectroscopic techniques and chemical methods. In addition, the structures of withanolides 1, 2, 3, and 6 were confirmed by X-ray crystallographic analysis. Using a MTS viability assay, eight withanolides (1, 2, 3, 7, 8, 15, 16, and 19) and four acetylated derivatives (1a, 1b, 2a, and 2b) showed potent cytotoxicity against human head and neck squamous cell carcinoma (JMAR and MDA-1986), melanoma (B16F10 and SKMEL-28), and normal fetal fibroblast (MRC-5) cells with IC50 values in the range between 0.067 and 9.3 μM.
- 18 November 2011
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 74 (12) , 2532-2544
Cytotoxic Withanolide Constituents of Physalis longifolia
Fourteen new withanolides, 1–14, named withalongolides A–N, respectively, were isolated from the aerial parts of Physalis longifolia together with eight known compounds (15–22). The structures of compounds 1–14 were elucidated through spectroscopic techniques and chemical methods. In addition, the structures of withanolides 1, 2, 3, and 6 were confirmed by X-ray crystallographic analysis. Using a MTS viability assay, eight withanolides (1, 2, 3, 7, 8, 15, 16, and 19) and four acetylated derivatives (1a, 1b, 2a, and 2b) showed potent cytotoxicity against human head and neck squamous cell carcinoma (JMAR and MDA-1986), melanoma (B16F10 and SKMEL-28), and normal fetal fibroblast (MRC-5) cells with IC50 values in the range between 0.067 and 9.3 μM.